San Diego, CA, United States of America

Betty Lam

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 47(Granted Patents)


Location History:

  • Spring Valley, CA (US) (2010 - 2013)
  • San Diego, CA (US) (2012 - 2021)

Company Filing History:


Years Active: 2010-2025

where 'Filed Patents' based on already Granted Patents

16 patents (USPTO):

Title: Innovations in Pharmaceuticals: The Contributions of Betty Lam

Introduction: Betty Lam, based in San Diego, CA, has made significant strides in the field of pharmaceuticals, holding a remarkable portfolio of 15 patents. Her work primarily focuses on the development of innovative compounds that target critical mechanisms in the treatment of diseases, including cancer.

Latest Patents: Among her latest patents are groundbreaking pharmaceutical compositions that comprise WRN helicase inhibitors. These compositions include compounds of Formula (I) or their pharmaceutically acceptable salts or solvates. The patented compounds act as inhibitors of WRN helicase and have potential applications in treating proliferative diseases such as cancer. Another notable patent involves 4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139. This invention presents a method for treating various diseases associated with GPR139 by utilizing specific compounds that are agonists of this receptor. The patent details not only the compounds but also the pharmaceutical compositions and processes for synthesizing them, demonstrating her innovative approach to tackling complex medical challenges.

Career Highlights: Betty Lam has established a notable career in the pharmaceutical industry, contributing to advancements in drug development and therapeutic strategies. She has worked with esteemed organizations such as Takeda Pharmaceutical Company Limited, where her research has led to the creation of valuable patentable innovations. Her role in these companies marks her as a leading figure in the field, driving forward the frontiers of medical science.

Collaborations: Throughout her career, Betty has collaborated with distinguished colleagues, including Stephen A Hitchcock and Holger Monenschein. These partnerships have enhanced her research initiatives and fostered innovations that contribute to impactful medical treatments.

Conclusion: Betty Lam is a prominent inventor in the pharmaceutical domain, recognized for her significant contributions through her 15 patents. Her work on WRN helicase inhibitors and modulators of GPR139 illustrates her commitment to advancing treatment options for serious health conditions. As the pharmaceutical landscape continues to evolve, innovations like those spearheaded by Lam offer hope for more effective therapies in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…